Qaiser Bashir
0000-0002-4086-6453
11 papers found
Refreshing results…
Single‐agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience
A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation
KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome
Gene expression profiling predicts relapse‐free and overall survival in newly diagnosed myeloma patients treated with novel therapies
Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report
Impact of TKI maintenance post-allogeneic transplant in Philadelphia positive acute lymphoblastic leukemia
Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?
Panobinostat and venetoclax enhance the cytotoxicity of gemcitabine, busulfan, and melphalan in multiple myeloma cells
Missing publications? Search for publications with a matching author name.